/Investor DB

Axial VC — Full Portfolio

63 tracked investments · listed companies and verified rows first

Adaptyvadaptyvbio.comin𝕏Seed

Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials.

AI & Machine LearningBiotechDeep TechHealthtechLausanne, CH

Julian Englert(Founder)inDaniel Nakhaee-Zadeh Gutierrez(Founder)inRobert KapturinGerard AntouninSam BurnsinDaniel Nakhaee-Zadeh(CTO)in

Co-investorsFoundersHAWKTAILHighland EuropeLong GameNeer Venture PartnersRheingau Founders+11 more

AlgoViralalgoviral.cominSeed

AlgoViral helps high-growth startups scale their social media presence using AI and data-driven automation.

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSLondon, GB

Jonathan Baker(Founder)inPhilip Howson(Founder)in

Co-investorsInterwoven VenturesY CombinatorAgrolimen VenturesGaingelsGlobal Founders CapitalNKM Capital+4 more

Aperiam Bioaperiambio.comin

Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.

AI & Machine LearningBiotechDeep TechAustin, US

Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)inRussell Durrett(Chief Business Officer)

Co-investorsCivilization Ventures Management, LlcOMX VenturesKdT Ventures

Arda Therapeuticsardatx.comin𝕏

Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.

AI & Machine LearningBiotechDigital HealthLongevityMedical DevicesAustin, US

Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder and Chief Technology Officer)in

BoardVineeta Agarwala(Director)in

Co-investorsage1Alumni VenturesAndreessen HorowitzGaingelsGV (Google Ventures)Lifelink+7 more

attivareattivaretx.com

Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.

AI & Machine LearningBiotechMedical DevicesNatick, US

Edward Doherty(Executive Officer)Jessica McDonough(Director)Joaquim Trias(Executive Officer, Director)

BoardZeshan Muhammedi(Director)in

Co-investorsAAF Management Ltd.Divergent CapitalEmbark VenturesHarmonix FundMana VenturesMBX Capital+1 more

BigHat Biosciencesbighatbio.comin𝕏

Big Hat Bio develops therapeutics under development across multiple programs.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Peyton Greenside(Founder)inMark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)

BoardFrancisco Gimenez(Director)inSteve Kafka(Director)

Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGaingelsGRIDS Capital+12 more

BLUUMBIObluumbio.cominSeed

BluumBio identifies and deploys naturally occurring enzymes from fungi, trees, and bacteria to remove industrial pollutants from soil, air, and water.

BiotechCleantechHealthtechImpact & Social GoodSan Francisco, US

Katherine French(Founder)inKathrine French(Founder)

Co-investorsCollaborative FundHAWKTAILOlive Tree CapitalOxonian VenturesPlug and Play VenturesY Combinator+8 more

Bristlebristlehealth.comin𝕏

Bristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

David Lin(Founder)inBrian Maurer(Founder)inShivam Patel(Founder)inDanny Grannick

Co-investorsInitialized CapitalR/GA VenturesY Combinator645 VenturesBR CapitalNorth South Ventures

Catena Biosciencescatenabio.cominSeed

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Marco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen

Co-investorsCalifornia Innovation FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWGaingelsIaso Ventures+14 more

Cellafarmscellafarms.com𝕏

Cella Farms develops food products focused on complete protein, reduced sugar, and balanced nutrition.

ConsumerFoodTechWellness & Fitness

CHARM Therapeuticscharmtx.comin

CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.

AI & Machine LearningBiotechHealthtechLondon

Lakshyaditya Singh Aithani(Executive Officer, Director)David Baker(Founder)Laksh Aithani(Founder)

BoardRishi Gupta(Director)inNihal Sinha(Director)inMuzammil Mansuri(Director)in

Co-investorsF-Prime CapitalNew Enterprise Associates (NEA)NVIDIAOrbiMedSR One Capital ManagementKhosla Ventures+1 more

Colorado Biofactorycoloradobiofactory.comin𝕏Nov 2024

ZymeCO creates enzyme-based bio-solutions that accelerate decomposition of organic matter in soil and turf, serving agriculture and golf course management.

AgTechBiotechImpact & Social GoodColorado Springs, US

Thaddaus Huber(Executive Officer, Director)Mark Slavens(CEO)

BoardRik Wehbring(Director)Michael Cantrell(Director)

Concertoconcertobio.comin𝕏

Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition.

AI & Machine LearningBiotechDeep TechCambridge, US

Jared Kehe(Executive Officer, Director)inCheri Ackerman(Executive Officer, Director)inBernardo Cervantes(Executive Officer, Director)inVera Schroeder(Director)in

BoardSarah Luppino(Director)in

Co-investorsAlumni VenturesExcelestar VenturesGolden SeedsHorizons VenturesISVM Ventures+4 more

Deciduous Therapeuticsdeciduoustx.cominJun 2019

Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.

BiotechDigital HealthLongevitySan Francisco, US

Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in

BoardDylan Morris(Director)in

Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)GaingelsLifespan Vision Ventures+4 more

Delixdelixtherapeutics.comin

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalDolby Family VenturesGaingelsNoetic+8 more

Enable Medicineenablemedicine.cominAug 2020

Enable Medicine builds an integrated biological data platform that organizes and links clinical, spatial, cellular, and molecular data from patients and studies into a unified index to accelerate therapeutic discovery and diagnostics for researchers.

AI & Machine LearningBiotechData & InfrastructureMenlo Park, US

Sunil Bodapati(Executive Officer, Director)inAaron Mayer(Director)in

Co-investorsBreyer CapitalInitialized CapitalWPSS InvestmentsInertia Ventures

Euler Bioeuler.bio

Euler Biologics develops antibody-based therapies aimed at preserving and enhancing physical function in older adults to support healthy aging and functional independence.

BiotechHealthtechLongevity

Co-investorsGaingelsPillar VCSoma Capital

FastFarmafastfarma.comin𝕏SeedDefunct

FastFarma operates an online pharmacy platform serving Latin American customers, offering price-competitive medications with rapid delivery.

E-commerceHealthtechWellness & FitnessQuito, EC

Santiago Ribadeneira(Founder)inMarcelo Albuja(Founder)inJuan Carlos Holguin

Co-investorsY Combinator0BSAsymmetry VenturesBankia Fintech VentureBuenTrip VenturesGoodwater Capital+10 more

Glyphic Biotechnologiesglyphic.bioin𝕏Feb 2024

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)

BoardCraig Asher(Director)inJimmy Yun(Director)in

Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesGaingelsHarpoon Ventures+10 more

Gradia Healthgradia.cominSeed

Gradia provides a virtual care platform for patients with chronic conditions, offering integrated communication and specialized care coordination between clinic appointments to supplement traditional in-person care.

Digital HealthHealthtechSaaSSan Francisco, US

Rithvik Seela(Founder)inAndrew Zelaya(Founder)inFarzaan Kaiyomprathik m(Founding Engineer)Hazel Cruz(Recruiter)Veronica Lode(Founding Dietician)

Co-investorsAtlanta Tech VillageJude GomilaMaC Venture CapitalSoma CapitalY CombinatorHarvard Management Company+5 more

HTuO Bioscienceshtuobio.comin𝕏

Vancouver-based computational drug discovery company using physics-based molecular simulation to target hard-to-drug proteins.

Co-investorsAngel ForumCognition FundSwan Venture FundWUTIF CapitalYork Angel Investors Inc.

Inductive Bioinductive.bioin𝕏Mar 2025

Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.

AI & Machine LearningBiotechDeep TechBrooklyn, US

Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in

BoardRohan Ganesh(Director)in

Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsEnsemble LabsLux CapitalObvious Ventures+5 more

Infinimmuneinfinimmune.comin

Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.

AI & Machine LearningBiotechMedical Devices

Lance Hepler(Founder)inKatie Pfeiffer(Founder)inMichael Gibbons(Founder)inWyatt McDonnell(Founder)indavid jaffe(Founder)inDavid Jaffe(Founder)

Co-investorsCivilization Ventures Management, LlcPear VCPlayground GlobalRA CapitalPaladin Capital GroupTrammell Venture Partners (TVP)

Insamoinsamo.com

Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.

AI & Machine LearningBiotechDeep TechChippendale, AU

Tim Craven(CEO)inToby Passioura(Founder)inGlen McIntyre(Founder)Timothy Craven(Founder)

BoardCOREY GOODMAN(Director)inMATT HERSHENSON(Director)in

Co-investorsBEVCCivilization Ventures Management, LlcMRL Ventures FundPlayground GlobalvenBio PartnersvenBio Global Strategic

Kiwi Biosciencesfodzyme.comin𝕏Seed

FODZYME develops an enzyme powder supplement that breaks down FODMAPs in food, particularly fructans found in garlic, onions, and wheat, for people with digestive sensitivities.

BiotechConsumerFoodTechHealthtechWellness & FitnessBoston, US

Anjie Liu(Founder)inDavid Hachuel Gurska(Founder)in

Co-investorsGaingelsY CombinatorAcacia Venture Capital PartnersAileron Project LtdFAST — by GETTYLABFortem Capital+6 more

LatchBiolatch.bioin𝕏

Latch builds data infrastructure and software tools for biological computing, enabling researchers to program and automate biological discovery through high-throughput laboratory automation and machine learning.

AI & Machine LearningBiotechData & InfrastructureDeep Tech

Alfredo Andere(Founder)inKyle Giffin(Founder)inKenny Workman(Founder)in

Co-investorsCoatue ManagementFifty YearsHummingbird VenturesMantis CapitalSwift VenturesCaffeinated Capital+2 more

Lyelllyell.cominMar 2020

Lyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology.

BiotechDeep TechHealthtechMedical DevicesBothell, US

Stan Riddell(Executive Officer)Richard Klausner(Executive Officer, Director, Promoter)Stephen Hill(Executive Officer)inHeather Turner(Executive Officer)inRichard Goold(Executive Officer)inMargo Roberts(Executive Officer)

Co-investorsARCH Venture PartnersForesite CapitalvenBio Partners8VC

Lyellbiotechlyellbiotech.com

Lyell Immunopharma is a Nasdaq-listed cell therapy developer engineering T cell therapies for solid tumors and blood cancers.

Co-investorsARCH Venture PartnersForesite Capital

Meliora Therapeuticsmelioratherapeutics.comin

Machine learning and data platform for understanding how diseases fight back and resist therapies

David Li(Founder)in

Co-investorsHAWKTAILJude GomilaValkyrieBrightEdgeHOF CapitalObvious Ventures+3 more

Mindedminded.comin𝕏

Minded provides an AI agent that automates repetitive business tasks like customer refunds, data entry, reporting, and onboarding by learning workflows from single demonstrations and executing them across tools like Slack, Gmail, Teams, and Chrome.

AI & Machine LearningEnterprise SoftwareSaaSTel Aviv-Yafo, IL

Ohad Navon(Founder)inNadav Zamir(Founder)in

Co-investorsPioneerY CombinatorEarl Grey CapitalFundersClubGaingelsLink Ventures+6 more

Nexiliconexilico.com

Nexilico is a biotech company that uses an AI-driven discovery platform and proprietary microbiome digital twin technology to engineer the microbiome for precision medicine.

AI & Machine LearningBiotechDigital Health

Nuanced Healthnuancedhealth.comin

Nuanced Health develops healthcare solutions, though the specific product focus is not detailed on this team page.

AI & Machine LearningBiotechDeep TechHealthtechLos Angeles, US

Sarkis Mazmanian(Co-Founder)inYan Yang(Chief Scientific Officer)in

Co-investorsFREEFLOWOpen Field Capital

Options MDoptionsmd.comin

Wellness & FitnessLos Angeles, US

Kyle Pierce(Executive Officer, Director)inMorgan Hewett(Executive Officer, Director)in

Co-investorsAlumni VenturesBread And Butter Ventures, LlcGaingelsM13MedMountain VenturesTechstars+2 more

Papapapa.comin𝕏

Papa is a platform that connects older adults and families with trained companion caregivers for in-home companionship and support services.

ConsumerDigital HealthHealthtechSocialWellness & FitnessMiami, US

Andrew Parker(Founder and CEO)inAlfredo Vaamonde(Co-Founder of Papa; Director)inCharles Hector(Executive Officer)Amit Salam(Senior Technical Recruiter)

BoardByron Ling(Director)inFatima Husain(Director)in

Co-investorsComcast VenturesCanaan PartnersCapital B Private HoldingsFJ LabsInitialized CapitalIntegra Groupe+14 more

Parallel Bioparallel.bioin𝕏Seed

Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

Robert DiFazio(Founder)inJuliana Hilliard(Founder)injennifer lee(Vice President of Finance \u0026 Operations)Christopher Riling(Vice President of Science)

Co-investorsAIX VenturesBreakout VenturesGaingelsHumba VenturesImmeasurableJulian Capital+19 more

Parallelhealthparallelhealth.ioin

Parallel Health offers a skincare product line addressing aging through microbiome science, including peptide creams and cleansers designed to target the hallmarks of skin aging.

BiotechConsumerDigital HealthDirect to ConsumerHealthtechWellness & Fitness

Nathan Brown(Founder)inNatalise Kalea Robinson(Founder)

Co-investorsFirst In VenturesSand Hill AngelsHyphen Capital

Potionpotion.aiinSeed

Potion creates automation and workflow solutions for beauty and personal care companies to reduce time spent on repetitive tasks.

AI & Machine LearningConsumerEnterprise SoftwareMarketing TechSaaSSan Francisco, US

Yahya Syed(Founder)inHejab Malik(Founder)inAlex Stec(Founder)inJonathan He(Founder)Marcella Valentine(Operations Lead)Laura Conwill(Software Engineer)

Co-investorsHAWKTAILSeven Seven SixY CombinatorBeagle VenturesCenterview Partners InvestmentsHarvard Management Company+3 more

Reference Medicinereferencemedicine.comin𝕏

Reference Medicine supplies biological specimens to researchers and diagnostics developers working on cancer diagnostic tools.

AI & Machine LearningB2B MarketplacesBiotechDigital HealthHealthtechMedical Devices

Co-investorsMetaplanet

Replay Therapeuticsreplay.bio

Replay develops gene therapies for patients with rare genetic diseases.

BiotechHealthtechLongevity

Lachlan MacKinnon(CEO and Founder)Adrian Woolfson(Founder)Robert Coffin(Executive Chairman)Maria Castner-Miller(General Counsel)inRenata Martin(VP & Head of Gene Therapy)inSaurabh Sharma(VP & Head of CMC)

Co-investorsArtis VenturesGaingelsOMX VenturesSolari Capital

Revelagetrevela.com

The site presents Thai-language promotional content for online slot ("สล็อตเว็บตรง") gambling, listing direct-web slot sites with automatic wallet deposits/withdrawals and hundreds of games.

Co-investorsBantam GroupTaihill VentureHyphen Capital

Rubi Labsrubi.earthin𝕏Feb 2022 · $4.5M

Rubi develops biotechnology solutions for sustainable manufacturing in the fashion and textiles industry.

Advanced ManufacturingBiotechCleantechClimate TechNew MaterialsSan Francisco, US

Neeka Mashouf(Co-founder)inLeila Mashouf(Co-founder)in

BoardDaria Hosseinyoun(Director)inRohini Finch(Director)in

Co-investorsAP VenturesClimacticCollaborative FundDarco CapitalJuniperKayak Ventures+7 more

Saniarxsaniarx.comin𝕏

SaniaRx develops precision therapies targeting the central and peripheral nervous system to treat prevalent, underserved disease areas using targeted vector delivery and controllable therapeutics.

BiotechDeep TechMedical DevicesLondon, GB

Scispotscispot.ioin𝕏Seed

Scispot provides automated sample tracking and traceability software for laboratory environments, replacing manual processes and spreadsheets with end-to-end logging and monitoring capabilities.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaSKitchener, CA

Guru Singh(Founder)inSatya Singh(Founder)inNash SeshanRitesh Agarwal(Infra)

Co-investorsY CombinatorAvenue Growth PartnersBreakwater VenturesHarvard Management CompanyIncisive VenturesPack Ventures+1 more

Seranova Bioseranovabio.comin

Seranova is a biotech company that combines REAP autoantibody profiling with clinically linked patient cohorts to identify naturally occurring protective autoantibodies against specific extracellular targets and translate those protective associations into therapeutic hypotheses.

AI & Machine LearningBiotechDeep TechNew Haven, US

Aaron Ring(Manager)inBeatrice McQueen(Executive Officer)

BoardJim Tananbaum(Manager)

Co-investorsARCH Venture PartnersForesite Capital

Serna Bioserna.bioin𝕏Seed

Serna builds a platform to unlock the transcriptome as a drug target for drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechOntario, US

Rabia Khan(Founder)inAaron Lazarus(Chief of Staff)inPaul Bradley-Law(Head of People Ops)

Co-investorsBackedHummingbird VenturesLifeforce CapitalY CombinatorAME Cloud VenturesAmino Collective+3 more

Simcha Therapeuticssimchatx.comin

Simcha is a biotechnology company developing new cancer medicines based on immune biology research.

BiotechHealthtechNew Haven, US

Aaron Ring(Executive Officer, Director)inBeatrice McQueen(Chief Operating Officer)inSanuj Ravindran(Chief Executive Officer)Jeremy Barton(Chief Medical Director)Hirdesh Uppal(Senior Vice President Translational Research and Development Sciences)Joseph Catino(Executive Officer)

Co-investorsConnecticut InnovationsPfizer Venture InvestmentsSR One Capital ManagementBiotechnology Value FundRock Springs CapitalSamsara BioCapital

Stately Biostatelybio.cominMay 2025

Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.

AI & Machine LearningBiotechMedical Devices

Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)

Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentBoxOne VenturesCaffeinated CapitalDimension Capital+1 more

Stipple Biostipple.bioin𝕏

Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.

BiotechHealthtechCambridge, US

Aaron Ring(Co-founder)inAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRoland Gendron(Chief Business Officer)inMichelle Zhang(Chief Scientific Officer)in

BoardVineeta Agarwala(Director)in

Co-investorsRA CapitalAndreessen HorowitzGV (Google Ventures)Magnetic VenturesOMX VenturesLoLa Capital Partners+1 more

SynsoryBiosynsorybio.cominSeed

SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.

BiotechHealthtechBoston, US

Elliot Tague(Founder)inNathan Tague(Founder)in

Co-investorsGurtin VenturesY CombinatorAgrolimen VenturesFriends Family CapitalPhoenix FundUnpopular Ventures

Talus Biotalus.bioin𝕏Seed · Jul 2024

Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.

AI & Machine LearningBiotechDeep TechHealthtechSeattle, US

Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)

BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in

Co-investorsFarvatn VentureFifty YearsFundersClubGaingelsJude GomilaNFX+12 more

Talusbiosciencetalusbioscience.comin

Talus is a drug discovery company with a proprietary platform that measures and modulates the regulome — the transcription factors, cofactors, and splicing regulators controlling gene expression — in live cells using functional proteomics and AI models.

AI & Machine LearningBiotechDeep Tech

Alex Federation(Ph.D.)Christopher Joyce(MBA)Lindsay Pino(Ph.D.)Michelle BriscoeWill Fondrie(Ph.D.)

Thatch Healththatch.comin𝕏

Thatch provides APIs and embeddable components that enable platforms and software providers to offer ICHRA (Individual Coverage Health Reimbursement Arrangement) benefits to their customers.

Enterprise SoftwareFintechHealthtechHR TechInsurTechSaaS

Adam Stevenson(Founder)inChris Ellis(Founder)

Co-investorsAndreessen HorowitzAvid VenturesGeneral PartnershipIndex VenturesLux CapitalNotre Dame Founders Fund+6 more

Think Biosciencethinkbioscience.comin

Think Bioscience develops new medicines for diseases with limited treatment options through synthetic biology and computational chemistry.

BiotechDeep Tech

Co-investorsAV8 VenturesBuff Gold VenturesColorado BioScience AssociationCU Healthcare Innovation FundWireframe VenturesInnovation Endeavors

Tilda Researchtilda.bioin

Tilda Research provides AI-powered teammates designed to streamline clinical trial operations for sponsors, contract research organizations, and research sites by automating data management and workflow processes.

AI & Machine LearningHealthtechMedical Devices

Ram Yalamanchili(Founder/CEO)in

Co-investors8VCOptum VenturesStorm Ventures

Trestle Biotherapeuticstrestlebio.cominSeed

Trestle Biotherapeutics develops bioengineered implantable tissues designed to treat end-stage renal disease, aiming to get patients off dialysis and eventually provide replacement organs.

BiotechDeep TechHealthtechMedical DevicesSan Diego, US

Ben Shepherd(Founder)inAlice Chen(Founder)inAlice Chen, PhD(Co-founder and Chief Scientific Officer)inBen Shepherd, PhD(Co-Founder and Chief Executive Officer)

Co-investorsY CombinatorBlack Mountain VentuesC3 VenturesDraper AssociatesAcequia Capital (AceCap)Agrolimen Ventures+5 more

Zeit Medicalzeitmedical.comin𝕏SeedDefunct

Zeit Medical develops a wearable headband with AI-powered sensors that detects strokes in real time and automatically alerts emergency services, targeting patients at high risk for stroke who may be asleep or unable to call for help themselves.

HealthtechMedical DevicesSan Francisco, US

Orestis Vardoulis(Founder)inUrs Naber(Founder)inDavid Flatow(Tech Lead)Athanasios Vlontzos(data engineer)

Co-investorsCitta CapitalFoundersGaingelsY CombinatorHike VenturesHydrocarbon Minerals 4+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Appia BioImmulusLaddertxOmicaRubi LaboratoriesSania TherapeuticsTryminded

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.